People who don’t have one of the “big four” most common cancers – breast, bowel, lung or prostate – may feel that their disease gets less attention from the media and a smaller chunk of research funding. But rarer cancers present unique research challenges and, behind the scenes, many scientists and clinicians are looking for ways to improve this situation.
At the NCRI Cancer Conference a session devoted to discussing these issues attracted a varied audience, including many people who had been treated for a rare type of cancer, as well as clinicians and policy makers.
Posted by juliesharp 
Welcome to the
